QQQ   357.86 (-1.83%)
AAPL   173.93 (-0.89%)
MSFT   319.53 (-0.39%)
META   295.73 (-1.31%)
GOOGL   130.44 (-2.47%)
AMZN   129.33 (-4.41%)
TSLA   255.70 (-2.62%)
NVDA   410.17 (-2.89%)
NIO   8.46 (-4.19%)
BABA   84.12 (-1.89%)
AMD   96.11 (-4.22%)
T   15.31 (-1.61%)
F   12.20 (-1.30%)
MU   67.90 (-2.55%)
CGC   0.77 (-11.53%)
GE   112.97 (-1.64%)
DIS   82.73 (+0.21%)
AMC   7.71 (-5.51%)
PFE   32.85 (-2.29%)
PYPL   58.62 (-3.68%)
NFLX   384.15 (-0.56%)
QQQ   357.86 (-1.83%)
AAPL   173.93 (-0.89%)
MSFT   319.53 (-0.39%)
META   295.73 (-1.31%)
GOOGL   130.44 (-2.47%)
AMZN   129.33 (-4.41%)
TSLA   255.70 (-2.62%)
NVDA   410.17 (-2.89%)
NIO   8.46 (-4.19%)
BABA   84.12 (-1.89%)
AMD   96.11 (-4.22%)
T   15.31 (-1.61%)
F   12.20 (-1.30%)
MU   67.90 (-2.55%)
CGC   0.77 (-11.53%)
GE   112.97 (-1.64%)
DIS   82.73 (+0.21%)
AMC   7.71 (-5.51%)
PFE   32.85 (-2.29%)
PYPL   58.62 (-3.68%)
NFLX   384.15 (-0.56%)
QQQ   357.86 (-1.83%)
AAPL   173.93 (-0.89%)
MSFT   319.53 (-0.39%)
META   295.73 (-1.31%)
GOOGL   130.44 (-2.47%)
AMZN   129.33 (-4.41%)
TSLA   255.70 (-2.62%)
NVDA   410.17 (-2.89%)
NIO   8.46 (-4.19%)
BABA   84.12 (-1.89%)
AMD   96.11 (-4.22%)
T   15.31 (-1.61%)
F   12.20 (-1.30%)
MU   67.90 (-2.55%)
CGC   0.77 (-11.53%)
GE   112.97 (-1.64%)
DIS   82.73 (+0.21%)
AMC   7.71 (-5.51%)
PFE   32.85 (-2.29%)
PYPL   58.62 (-3.68%)
NFLX   384.15 (-0.56%)
QQQ   357.86 (-1.83%)
AAPL   173.93 (-0.89%)
MSFT   319.53 (-0.39%)
META   295.73 (-1.31%)
GOOGL   130.44 (-2.47%)
AMZN   129.33 (-4.41%)
TSLA   255.70 (-2.62%)
NVDA   410.17 (-2.89%)
NIO   8.46 (-4.19%)
BABA   84.12 (-1.89%)
AMD   96.11 (-4.22%)
T   15.31 (-1.61%)
F   12.20 (-1.30%)
MU   67.90 (-2.55%)
CGC   0.77 (-11.53%)
GE   112.97 (-1.64%)
DIS   82.73 (+0.21%)
AMC   7.71 (-5.51%)
PFE   32.85 (-2.29%)
PYPL   58.62 (-3.68%)
NFLX   384.15 (-0.56%)
NASDAQ:SPRO

Spero Therapeutics (SPRO) Short Interest Ratio & Short Volume

$1.22
-0.01 (-0.81%)
(As of 09/21/2023 ET)
Compare
Today's Range
$1.20
▼
$1.24
50-Day Range
$1.22
▼
$1.63
52-Week Range
$1.20
▼
$3.18
Volume
189,679 shs
Average Volume
416,667 shs
Market Capitalization
$64.32 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$7.50
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability

Spero Therapeutics Short Interest Data

Current Short Volume
1,140,000 shares
Previous Short Volume
1,140,000 shares
Change Vs. Previous Month
No Change
Dollar Volume Sold Short
$1.71 million
Short Interest Ratio / Days to Cover
3.2
Last Record Date
August 31, 2023
Outstanding Shares
52,720,000 shares
Percentage of Shares Shorted
2.16%
Today's Trading Volume
189,679 shares
Average Trading Volume
416,667 shares
Today's Volume Vs. Average
46%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Spero Therapeutics ?

Sign up to receive the latest short interest report for Spero Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History
Short InterestDays to CoverShort Percent of Float

SPRO Short Interest Over Time

SPRO Days to Cover Over Time

SPRO Percentage of Float Shorted Over Time


Spero Therapeutics (NASDAQ:SPRO) Short Interest History

Export to Excel
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
8/31/20231,140,000 shares $1.71 million No ChangeN/A3.2 $1.50
8/15/20231,140,000 shares $1.53 million -2.6%N/A3.8 $1.35
7/31/20231,170,000 shares $1.91 million No ChangeN/A3.9 $1.63
7/15/20231,170,000 shares $1.77 million -4.9%N/A4.2 $1.51
6/30/20231,230,000 shares $1.78 million +40.4%N/A4 $1.45
6/15/2023876,300 shares $1.38 million -0.6%N/A1.8 $1.57
5/31/2023881,800 shares $1.53 million -9.5%N/A1.7 $1.74
5/15/2023974,400 shares $1.82 million -32.8%N/A1.7 $1.87
4/30/20231,450,000 shares $2.57 million -21.6%N/A2.5 $1.77
4/15/20231,850,000 shares $3.18 million +17.1%N/A3.3 $1.72
3/31/20231,580,000 shares $2.29 million +67.6%N/A2.8 $1.45
3/15/2023942,700 shares $1.39 million +142.0%N/A2.1 $1.47
2/28/2023389,500 shares $576,460.00 +35.5%N/A0.9 $1.48
2/15/2023287,400 shares $514,446.00 -38.6%N/A0.7 $1.79
1/31/2023468,200 shares $866,170.00 -29.9%N/A0.8 $1.85
1/15/2023667,900 shares $1.34 million -21.4%N/A1.1 $2.00
12/30/2022849,400 shares $1.47 million -14.6%N/A1.1 $1.73
12/15/2022994,200 shares $1.69 million -23.5%N/A0.4 $1.70
11/30/20221,300,000 shares $2.52 million -13.9%N/A0.2 $1.94
11/15/20221,510,000 shares $2.84 million +22.8%5.5%0.2 $1.88
10/31/20221,230,000 shares $2.41 million -15.8%4.5%0.2 $1.96
10/15/20221,460,000 shares $2.89 million -32.4%5.4%0.2 $1.98
9/30/20222,160,000 shares $4.32 million +177.9%8.0%0.3 $2.00
9/15/2022777,200 shares $753,884.00 +182.0%2.9%0.1 $0.97
8/31/2022275,600 shares $222,381.64 -32.9%1.0%0.1 $0.81
8/15/2022410,600 shares $371,059.22 +1.1%1.5%1.3 $0.90
7/31/2022406,100 shares $297,346.42 -27.2%1.6%1.1 $0.73
7/15/2022557,800 shares $440,662.00 +34.9%2.3%0.8 $0.79
6/30/2022413,600 shares $306,477.60 -70.9%1.7%0.6 $0.74
6/15/20221,420,000 shares $1.36 million -9.0%5.8%1.9 $0.96
5/31/20221,560,000 shares $1.84 million -5.5%6.4%2.3 $1.18
5/15/20221,650,000 shares $2.82 million -55.3%6.8%2.6 $1.71
4/30/20223,690,000 shares $17.93 million +6.7%14.6%6.3 $4.86
4/15/20223,460,000 shares $21.14 million +6.5%13.7%16.7 $6.11
3/31/20223,250,000 shares $28.28 million +4.2%13.1%16.5 $8.70
3/15/20223,120,000 shares $25.40 million +5.4%12.6%18.6 $8.14
2/28/20222,960,000 shares $28.42 million +5.7%11.9%20.8 $9.60
2/15/20222,800,000 shares $27.94 million +12.0%11.3%19.6 $9.98
1/31/20222,500,000 shares $29.68 million +4.6%10.1%18.6 $11.87
1/15/20222,390,000 shares $31.55 million +4.4%9.4%21.1 $13.20













SPRO Short Interest - Frequently Asked Questions

What is Spero Therapeutics' current short interest?

Short interest is the volume of Spero Therapeutics shares that have been sold short but have not yet been covered or closed out. As of August 31st, investors have sold 1,140,000 shares of SPRO short. Learn More on Spero Therapeutics' current short interest.

What is a good short interest ratio for Spero Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SPRO shares currently have a short interest ratio of 3.0. Learn More on Spero Therapeutics's short interest ratio.

Which institutional investors are shorting Spero Therapeutics?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Spero Therapeutics: Citadel Advisors LLC, and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

How does Spero Therapeutics' short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Spero Therapeutics: Vaccitech plc (0.03%), Xilio Therapeutics, Inc. (0.39%), Homology Medicines, Inc. (0.67%), Clene Inc. (0.32%), Eyenovia, Inc. (3.48%), Tiziana Life Sciences Ltd (0.77%), Immunic, Inc. (5.36%), Eliem Therapeutics, Inc. (0.24%), ADC Therapeutics SA (8.12%), Adagene Inc. (0.07%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($3.69 billion), Canadian Natural Resources Limited ($3.67 billion), T-Mobile US, Inc. ($3.56 billion), Suncor Energy Inc. ($3.20 billion), Occidental Petroleum Co. ($3.19 billion), Celsius Holdings, Inc. ($2.09 billion), Tractor Supply ($2.08 billion), Moderna, Inc. ($2.04 billion), Royal Caribbean Cruises Ltd. ($2.00 billion), and Rivian Automotive, Inc. ($1.96 billion). View all of the most shorted stocks.

What does it mean to sell short Spero Therapeutics stock?

Short selling SPRO is an investing strategy that aims to generate trading profit from Spero Therapeutics as its price is falling. SPRO shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Spero Therapeutics?

A short squeeze for Spero Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of SPRO, which in turn drives the price of the stock up even further.

How often is Spero Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SPRO, twice per month. The most recent reporting period available is August, 31 2023.



More Short Interest Resources from MarketBeat

Related Companies:
Short Interest Tools:
This page (NASDAQ:SPRO) was last updated on 9/21/2023 by MarketBeat.com Staff

My Account -